Caffeine is a widely used psychostimulant that is associated with increased acetylcholine levels in mammalian brain and acetycholinesterase antagonism. Acetylcholine, a neuromodulator, plays an important role in the processing of visual information. One key example in human vision, thought to at least partly involve cholinergic neuromodulation, is perceptual surround suppression of contrast, whereby the perceived contrast of a pattern is altered by the presence of a neighbouring pattern. Perceptual surround suppression is weaker with pharmacological administration of donepezil (a centrally-acting acetylcholine enzyme inhibitor) in healthy human observers. Here, we test whether temporarily manipulating caffeine levels (from complete washout to a controlled dose of caffeine) has a similar effect on perceptual surround suppression in 21 healthy young adults (aged 20-24 years, 11 females). Neither ingestion of a caffeine pill nor placebo altered contrast judgments when the target pattern was presented on a uniform grey background (p=0.54). With caffeine ingestion, perceptual surround suppression strength was reduced relative to baseline (prior to pill ingestion, p=0.003) and placebo (p=0.029), irrespective of whether the surround was oriented parallel or orthogonal to the central target. While daily habitual caffeine consumption of low-to-moderate doses (<400 mg/day, estimated from a written questionnaire) is not predictive of performance, our study indicates that acute consumption of caffeine on the day of testing influences perceptual surround suppression strength. Perceptual surround suppression is predominantly attributed to inhibitory processes involving the major cortical inhibitory neurotransmitter, gamma-aminobutyric acid. Our results point to the involvement of other neuromodulators, possibly cholinergic, in perceptual surround suppression.
Introduction
Caffeine is the most widely consumed psychoactive substance. In addition to its well-known stimulant effects via adenosine receptor blockade in the brain (Fredholm et al., 1999; Ribeiro and Sebastiao, 2010) , caffeine can influence neurotransmission, including effects on the cholinergic (Pohanka, 2014) , dopaminergic (Garrett and Griffiths, 1997) , noradrenergic (Berkowitz et al., 1970) , and serotonergic (Berkowitz and Spector, 1971) pathways. Acetylcholine is a neuromodulator that is implicated in visual sensory processing. A well-studied visual perceptual phenomenon that is thought to at least partially involve acetylcholine (Kosovicheva et al., 2012 ) is surround suppression of contrast. Surround suppression of contrast describes the phenomena where the apparent contrast of a visual stimulus can be markedly affected by its surrounding context. Typically, the apparent contrast of a target (e.g. a striped grating pattern) is reduced when surrounded by a pattern of higher contrast, compared to when viewed in isolation (Cannon and Fullenkamp, 1991; Chubb et al., 1989; Ejima and Takahashi, 1985) . The strength of such perceptual suppression depends on a range of stimulus characteristics, such as the contrast (Ejima and Takahashi, 1985; Xing and Heeger, 2001 ) and orientation (Cavanaugh et al., 2002; Levitt and Lund, 1997; Xing and Heeger, 2000) of the neighbouring stimulus (the surround) relative to the central target. Perceptual surround suppressive effects show strong quantitative agreement with responses measured from human primary visual cortex (V1) using functional magnetic resonance imaging (fMRI) (Haynes et al., 2003; Joo et al., 2012; Pihlaja et al., 2008; Williams et al., 2003; Zenger-Landolt and Heeger, 2003) , which suggests V1 as the earliest cortical area with the neuronal architecture capable of mediating perceptual surround suppressive effects in humans. Convergent evidence from primate work also points to a complex interaction between intra-V1, feedforward and feedback connections to V1 as contributing to visual surround suppression (Angelucci and Bressloff, 2006) .
A recent study demonstrated that ingestion of the centrallyacting acetylcholine enzyme inhibitor, donepezil (Kosasa et al., 1999; Rogers et al., 1991) , reduces perceptual surround suppression of contrast in healthy adults (Kosovicheva et al., 2012 ). An alternate method for manipulating acetylcholine levels may be caffeine ingestion. Caffeine administration enhances acetylcholine release in the hippocampus of awake, freely moving rats (Carter et al., 1995) and in stimulated cerebral cortex slices of rats naïve to caffeine (Corradetti et al., 1986) . In addition, caffeine shows antagonistic effects on human acetylcholinesterase samples (Pohanka and Dobes, 2013) . There is also convergent evidence from human behavioural work supporting a role for caffeine in influencing the cholinergic system. Scopolamine is an anti-cholinergic drug that adversely affects performance on cognition tests. Riedel et al. (1995) demonstrated that scopolamine-induced deficits in short-term memory could be attenuated by acute consumption of caffeine, suggesting that caffeine has cognitionenhancing properties by acting, at least partly, through cholinergic pathways. If caffeine has cholinergic effects and potentially increases acetylcholine levels in the human brain, its ingestion may influence the strength of perceptual surround suppression of contrast.
In this study, we test the hypothesis that acute caffeine ingestion in healthy observers affects perceptual surround suppression of contrast by using a common task that is often used to investigate spatial contextual interactions in human vision (Kosovicheva et al., 2012; Yoon et al., 2009 Yoon et al., , 2010 Zenger-Landolt and Heeger, 2003) . We predicted that perceptual surround suppression strength would decrease following caffeine consumption (similar to the effects of donepezil). We presented surround grating patterns that were oriented parallel and orthogonal to the target pattern to determine whether the effect of caffeine on perceptual suppression was orientation-dependent, as there are both orientation specific and non-specific aspects of perceptual surround suppression (Schallmo and Murray, 2016) . If caffeine acts via a similar mechanism as donepezil to influence contrast perception, we hypothesise that the reduction in perceptual surround suppression following caffeine would only be present for the parallel surround condition, as previously reported by Kosovicheva et al. (2012) .
Methods

Participants
Experimental procedures were approved by the Human Research Ethics Committee of the University of Melbourne (ID #1646382) and complied with the tenets of the Declaration of Helsinki. Written informed consent was obtained prior to testing. Our research hypothesis was based on a previous study (Kosovicheva et al., 2012) that measured the effect of donepezil on surround suppression of perceived contrast in a group of 19 healthy, young observers (mean age 26 years), compared to a placebo pill. In that study, a paired t-test (drug vs placebo) found a significant difference in performance (group mean difference=1% contrast, standard deviation=1.3% contrast) with 90% power (alpha=0.05, two-tailed), rejecting the null hypothesis that the mean difference was 0% contrast. We aimed for a similar number of participants in our sample to be able to detect a comparable difference in perceptual surround suppression with and without acute caffeine ingestion. The final sample size was 21 young adults (aged 20-24 years, 11 females). All participants were screened to ensure visual acuity of 6/7.5 or better in each eye with habitual refractive correction, and no systemic conditions (e.g. diabetes, epilepsy) or medications (e.g. antidepressants) known to affect visual function.
Caffeine questionnaire
Participants completed a questionnaire modified from Modi et al. (2010) to evaluate caffeine intake over the past month. Participants indicated the frequency of consumption of food, beverages, and medications containing caffeine. Estimates of daily caffeine intake (mg/kg/day) were calculated based on the caffeine content (mg) per standard unit of consumption (see Table 1 from Modi et al., 2010) and normalised to the participant's weight (kg).
Experimental design
The experiment was a double-blind, placebo-controlled, randomised cross-over design. Participants attended two test sessions of up to 90 min each. As per previous studies (Colzato et al., 2005; Haskell et al., 2005) , participants refrained from consuming caffeine for 24 h prior to a test visit. A 12-hour caffeine washout period is sufficient to reduce salivary caffeine levels to negligible levels (< 1 mg/mL) in habitual and non-habitual caffeine consumers (Haskell et al., 2005) .
The first visit included the vision screening and estimates of daily caffeine intake (mg/kg/day) were calculated based on the caffeine content (mg) per standard unit of consumption (see Modi et al., 2010) and normalised to the participant's weight (kg). At each visit, participants completed pre-drug baseline visual perceptual tests (described in the next section) and then consumed one of two types of pills with water: The pills were white, uncoated, round tablets of approximately the same size with no engravings. The caffeine dosage (200 mg) was exactly two tablets and was chosen because a comparable amount of oral caffeine (250 mg) elicits changes in the blood-oxygen dependent magnetic resonance imaging (MRI) signal from the visual cortex in healthy adults (Laurienti et al., 2002) . Doses of 250 mg caffeine have also yielded measurable changes on a visual feature binding task in healthy young adults (Colzato et al., 2005) . The magnitude and timing of peak plasma caffeine levels following oral caffeine ingestion varies considerably amongst individuals (Fredholm et al., 1999; Robertson et al., 1978) . Nevertheless, we constrained the visual perceptual testing to occur within a specified time frame based on previous measures of the approximate time when an absolute dose of 250 mg caffeine reaches its peak plasma concentration in the majority (89%) of healthy young individuals (Robertson et al., 1978) . Hence, participants waited between 30-60 min, during which time participants waited quietly in the testing room, before repeating the visual perceptual tests. No other tasks were completed during the test session. The order of pill administration was randomised and prepared by author BNN who was neither tested nor conducted participant testing, so that all other investigators and participants were blinded. The second session was scheduled at least two days after the first to ensure caffeine washout.
Visual tasks
Participants were refractively corrected for near binocular viewing (40 cm). Gamma-corrected stimuli were generated off-line in Matlab R2013b (Mathworks, Natick, Massachusetts, USA) and presented on an iPad-3 tablet device (Apple Inc., Cupertino, California, USA; frame rate: 60 Hz; screen resolution: 2048×1536 pixels) using the open-access platform 'Psypad' (Turpin et al., 2014) . The Psypad app selects which stimulus image to display from the pre-generated library of images according to a customisable staircase procedure. The public image library and staircase configuration used for this study can be viewed on the Psypad server (http://server.psypad.net.au). An example test ('Annular centre-surround task, as appeared in J Psychopharmacol 2017') can be viewed in Psypad Demo mode. Stimuli were drawn as per Kosovicheva et al. (2012) , except that the stimulus size was scaled (reduced to 0.8 of the original size used by Kosovicheva et al., 2012) to fit the iPad screen at the working distance (40 cm). A central black fixation point was provided. The image background was set to mean luminance (172 cd/m 2 for an iPad at constant maximum brightness). Three surround conditions were tested: (a) no surround (b) parallel surround (c) orthogonal surround. For the 'no surround' condition, an annulus (inner radius: 2.5°, outer radius: 5°) was presented in the centre of the screen, consisting of a vertical sinusoidal grating (1.1 cycles/degree, 20% contrast) divided into four quadrants (Figure 1(a) ). One quadrant was randomly chosen to be of variable contrast. The stimulus appeared for 200 ms to minimise saccadic eye movements. Participants chose the odd quadrant out (four-alternative forced choice, 4AFC). For the remaining conditions (Figures 1(b) and (c)) the task was the same, except that the annulus was surrounded by sinusoidal gratings of the same spatial frequency and phase extending from 0-2.5° radius and from 5-10° radius (80% contrast).
Increment detection thresholds (relative to 20% reference contrast) were measured for each quadrant using four interleaved twodown one-up staircases of four reversals (step sizes: 4%, 2%, 1%, 1%), and were repeated twice. The staircases began at a suprathreshold increment level (20% contrast increment for no surround, 40% contrast increment for surround conditions). Thresholds were estimated at approximately the 70% probability of seeing (Wetherill and Levitt, 1965) . The final threshold was the average of the final two reversals of the two repeats, averaged across all four quadrants.
The no-surround condition was always tested first for training purposes, and because performance on this baseline task does not vary considerably among individuals. The remaining tasks were randomised, with half the group performing the parallel surround condition first (and vice versa) to balance for learning and/or fatigue effects. The visual perceptual tests took approximately 15 min, in addition to practice runs and rest breaks between trials.
Statistical analysis SPSS V22.0 (SPSS Inc., Chicago, Illinois, USA) was used for statistical analysis. Data were tested for normality (KolmogorovSmirnov test) and compared using a repeated measures analysis of variance (RM-ANOVA). Huynh-Feldt adjustments were made for non-spherical data. To compare the strength of suppression, a 'suppression index' was calculated (surround threshold/no surround threshold). A ratio of 1 indicates no effect of the surround. An index >1 indicates suppression, i.e. compared to having no surround, a larger contrast increment was required to reliably detect the odd quadrant. Cohen's d effect sizes were calculated to measure the change in suppression from baseline after caffeine ingestion, where effect sizes of d = 0.2, 0.5, 0.8 were considered small, medium, and large effects, respectively (Cohen, 2013) . For all comparisons, p<0.05 was considered statistically significant. Example stimuli used to measure perceptual surround suppression. Contrast increment detection thresholds were measured for three surround conditions: (a) no surround (b) parallel surround (c) orthogonal surround. Participants chose which of the four quadrants was the odd one out (the 'target') relative to the rest of the annulus (20% reference contrast). The surround was 80% contrast. In these examples, the top-right hand quadrant of the central annulus is the odd one out.
Results
All participants completed the testing and were asked to guess which pill had been consumed at each of the two visits. The proportion of correct responses (62%, 13 of 21 participants) was not significantly different from chance (50% guess rate; chi-square test of proportions: p=0.44), indicating a successful blinding procedure. The median wait time between pill ingestion and repeat visual perceptual testing was 35 min for caffeine (range: 30-56 min) and 33 min for placebo (range: 30-52 min). The distribution of time post-pill ingestion was the same for the two interventions (Kolmogorov-Smirnov test: p=0.59).
Baseline contrast increment thresholds
We first considered whether baseline performance prior to pill ingestion varied systematically across the two visits. Overall, thresholds were not significantly different at the two visits (RM-ANOVA main effect of visit .02), indicating that performance on all tasks was similar across test sessions. Hence, baseline data were pooled across both visits for subsequent comparisons. Consistent with previous literature in healthy observers (Cannon and Fullenkamp, 1991; Kosovicheva et al., 2012; Xing and Heeger, 2000; Yu and Levi, 2000) , contrast increment thresholds were higher for the parallel (mean ± standard deviation: 13.31%±4.32%) than orthogonal condition (10.38%±3.06%), relative to the no surround condition (4.74%±1.10%), demonstrating the expected pattern of orientationdependent surround suppression prior to any intervention.
Effect of interventions on the no surround condition
Our measure of surround suppression strength (suppression index) depended on performance on the no surround condition. We therefore determined whether the pills (caffeine versus placebo) had an effect on the no surround condition. No effect of intervention was found when baseline contrast increment thresholds (average of two visits) were compared with the thresholds observed following ingestion of caffeine and placebo (Figure 2 , main effect of intervention: F(2,40)=0.63, p=0.54, ƞ p 2 =0.03).
Effect of intervention on surround suppression strength
We found a main effect of intervention on surround suppression strength (Figure 3 ; F(1.59, 31.82)=8.79, p=0 .002, ƞ p 2 =0.31). After taking the caffeine pills, suppression strength was reduced for both parallel (Cohen's d=0.53 ) and orthogonal (d=0.54) surround conditions relative to baseline (Bonferroni pairwise comparisons: p=0.003) and placebo (p=0.029). There was no difference in suppression index between placebo and baseline (p>0.05), indicating that only caffeine, and not the vitamin pill, altered visual performance. Figure 4 plots the 'effect of caffeine' as the difference in suppression between having no caffeine (average of placebo and baseline) and having caffeine. The reduction in surround suppression strength following caffeine ingestion was similar for parallel and orthogonal surrounds (intervention×surround interaction: Huynh-Feldt ɛ=0.69, F(1.39,27.70)=0.38, p=0.61, ƞ p 2 =0.02).
Relationship to habitual caffeine consumption
Estimates of daily caffeine intake normalised to an individual's weight (mg/kg/day) ranged from 0.15-6.26 mg/kg/day (median=1.57 mg/kg/day). The highest habitual caffeine consumption observed in our cohort was 356 mg/day, which is slightly more than 2.5 cups of coffee per day. Hence, the range of habitual caffeine consumption in this study was low to moderate only. There was no relationship between the effect of caffeine on suppression index and daily caffeine intake estimates (Pearson correlation analysis: parallel r=−0. 18, p=0.44; orthogonal r=−0.10, p=0.65) . This implies that after caffeine washout (in this case, 24 h), acute caffeine consumption affects perceptual surround suppression independent of a person's reported routine caffeine consumption.
Discussion
We found that visual perceptual surround suppression was altered relative to baseline after a controlled, absolute dose of caffeine. Visual surround suppression tasks are considered perceptual analogues of neuronal centre-surround suppression in visual cortex, because stimulus properties (e.g. orientation, contrast) similarly influence human perception and primate visual cortical neural responses (Cannon and Fullenkamp, 1991; Chubb et al., 1989; Shushruth et al., 2013; Xing and Heeger, 2000; Yu et al., 2001 ). Numerous studies have measured perceptual surround suppression to investigate proposed alterations in neuronal mechanisms underlying the healthy ageing process McKendrick, 2009, 2012) , migraine (Battista et al., 2011 ), Alzheimer's disease (Zhuang et al., 2016) , schizophrenia (Dakin et al., 2005; Yoon et al., 2009) , depression (Golomb et al., 2009) , and bipolar disorder (Schallmo et al., 2015) . Perceptual surround suppression has even been considered a potential translational tool for use in clinical trials for schizophrenia Gold et al., 2012) . Although the average effect of caffeine relative to baseline performance is small (mean 0.07 difference in suppression index, see Figure 4 ), average group differences between control and clinical populations in perceptual surround suppression strength vary approximately from 0.14-0.15 in migraine (Battista et al., 2011 ), Alzheimer's (Zhuang et al., 2016) , depression (Golomb et al., 2009 ) and bipolar disorder (Schallmo et al., 2015) to 0.35-0.4 in schizophrenia (Yoon et al., 2009 ) and healthy ageing (Karas and McKendrick, 2012) . Our small but statistically significant effect of caffeine constitutes between 17-48% of previously reported average group differences in perceptual surround suppression. Our findings therefore have far-reaching implications for the interpretation of research findings. Peak concentration of oral caffeine occurs within 30-60 min (Fredholm et al., 1999; Robertson et al., 1978) , half of which remains in the body 4-5 h after initial ingestion (Blanchard and Sawers, 1983; Cook et al., 1976) . Thus, any caffeine consumed by a participant could still be present at significant plasma concentrations hours later on the same day. We demonstrate that oral caffeine ingestion can affect perceptual tests of surround suppression in as little as 30 min, suggesting that caffeine levels may need to be controlled for future experimental work. Facilitatory effects on mood, vigilance, and performance on psychomotor and cognitive tasks following acute caffeine ingestion are well-documented Attwood et al., 2007; Haskell et al., 2005; Smit and Rogers, 2000) , and are attributed to caffeine's antagonistic action at the level of adenosine receptors in the central nervous system (Fredholm et al., 1999; Ribeiro and Sebastiao, 2010) . Caffeine also influences the formation and release of a variety of neurotransmitters that are implicated in cognition, including noradrenaline, serotonin, acetylcholine, and dopamine (reviewed by Nehlig et al., 1992) . In our case, improved vigilance or attention does not readily explain the reduction in perceptual surround suppression of contrast because increment contrast detection thresholds for the no surround condition were unaffected by caffeine ingestion (see Figure 2) . Nevertheless, given caffeine's ability to modulate activation of cortical areas related to attention , it is worth considering whether attention may be a contributing factor in our study. A specific form of visual spatial attention, 'featurebased' attention, has recently been shown to modulate human perceptual surround suppression Murray, 2015a, 2015b) , which requires an observer to attend to a particular feature or stimulus attribute (e.g. orientation) that is present in both the centre (target) and surround pattern. If attention is directed to a stimulus feature that is the same for the centre and surround, perceptual surround suppression is enhanced relative to when the stimulus feature does not match. Our visual stimuli had fixed spatial frequency, contrast, size, and phase, with the only difference between centre and surround being the orientation (in order to test the orientation-specificity of the effect of caffeine). To comment on whether caffeine may have influenced attention, and specifically 'feature-based' visual spatial attention, would require a different experimental design where more than one stimulus feature is altered. Moreover, although attention was not explicitly controlled in the present study, spatial attention was evenly distributed across our visual stimuli -on any given trial, the odd quadrant was randomly chosen, and so observers did not benefit from focusing their attention to only one part of their field of view.
We also considered whether our results might be dependent on habitual caffeine consumption. On the one hand, tolerance to the effects of caffeine (e.g. on mood, sleep disruption, cardiovascular effects) develops quickly in a matter of days with frequent caffeine consumption (Fredholm et al., 1999) . On the other hand, while some studies find that high caffeine consumers are more likely than low-moderate consumers to experience positive effects of caffeine on certain cognitive tasks that measure speed of processing and reaction time (Attwood et al., 2007; Smit and Rogers, 2000) , there are also reports showing improved cognitive performance on attention and working memory tasks and selfrated alertness following caffeine consumption, irrespective of caffeine habit (Haskell et al., 2005 , Rogers et al., 2003 . We found no correlation between daily caffeine intake levels and the effect of caffeine on visual perceptual surround suppression, implying that acute caffeine consumption similarly influences visual performance on this specific task in habitual and infrequent caffeine consumers. The estimates of daily caffeine intake reported in this study varied from 0.15-6.26 mg/kg/day, or 10-356 mg/day. This range reflects the full spectrum of typical dietary caffeine consumption in healthy adults aged 19-30 years (10-90 th percentile=24-330 mg/day, data from the US National Health and Nutrition Examination Survey 2001 , (see Fulgoni et al., 2015 . The inclusion of participants with very low caffeine consumption (0-50 mg/day, 24% of participants) is also a strength of this study, as non-consumers of caffeine are notably rare (Haskell et al., 2005) . Furthermore, we considered caffeine intake from multiple sources, which better reflects normal human consumption, as opposed to studies that have only considered caffeine content in beverages (e.g. see Mitchell et al., 2014) . A possible limitation of our experiments is that we did not control tightly for the time of day of the experiments. Previous research has shown that the effect of caffeine on somnolence (sleepiness) and subjective mood is influenced by an interaction between circadian typology and time of day (Adan et al., 2008) . Alertness and mood are not known contributing factors to our visual perceptual measures. All of our participants were tested between 11:00-18:00; however, tight control on the visit timing between the first and second session for a given individual was not enforced. Time of day did not influence the effect of caffeine on our primary outcome measure (change in suppression index from baseline to post-caffeine pill, results not shown). Nevertheless, ensuring that the placebo and caffeine sessions are conducted at the same time of day for each individual would likely decrease noise in the data, and should be considered for future studies.
We observed visual perceptual changes after only a moderate, absolute dose of caffeine (200 mg), which was chosen to be comparable to previous work in healthy young adults reporting changes in visual cortical responses with MRI (Laurienti et al., 2002) and visual perceptual feature binding (Colzato et al., 2005) with caffeine. Other studies have opted for higher doses (400 mg) of caffeine to produce robust effects (not seen with 250 mg) in improving mood and cognitive performance (e.g. see Attwood et al., 2007) . Oral administration of caffeine increases extracellular levels of cortical acetylcholine in awake rats in a dose-dependent manner (Carter et al., 1995) . Whether the visual perceptual changes observed here with acute caffeine consumption are similarly dose-dependent is unknown and requires further controlled testing with caffeine doses that are tailored to a person's weight. Furthermore, given the wide range of individual factors that may interact with caffeine (e.g. use of alcohol, illicit drugs, oral contraceptives, anticonvulsant drugs, and smoking), it would be necessary to measure the pharmacokinetics of caffeine in a given individual over an extended period of time (e.g. six hours).
In this study, caffeine equally influenced perceptual suppression in the presence of parallel and orthogonal surround stimuli, unlike donepezil's effect that is specific to parallel surround stimuli (Kosovicheva et al., 2012) . Several distinct neural mechanisms are considered to contribute to perceptual surround suppression: one that is orientation specific, and another that is non-orientation specific (Schallmo and Murray, 2016) . Our findings suggest that caffeine's predominant effect is on the non-orientation specific aspect of perceptual surround suppression. Our motivation for this study arose from caffeine's purported effect of increasing cortical acetylcholine. We chose to focus particularly on the cholinergic system because suppression of perceived contrast is a spatial contextual phenomenon, and systemic cholinergic enhancement with donepezil has been shown to influence the spatial spread of human fMRI responses from early visual areas -particularly V1 (Silver et al., 2008) , which is believed to be the neural locus of perceptual suppression of contrast (Haynes et al., 2003; Joo et al., 2012; Pihlaja et al., 2008; Williams et al., 2003; Zenger-Landolt and Heeger, 2003) . Further support for primarily considering the cholinergic system comes from a more recent study by Gratton et al. (2017) investigating visual spatial perception in healthy human observers. In that study, high-contrast flanking distractors were used to produce a perceptual suppressive effect by reducing an observer's ability to detect a difference in contrast (in this case, a contrast decrement) of a peripherally placed target (3° eccentricity). Pharmacological cholinergic enhancement with donepezil improved detection of the contrast target, but no such effects were seen with dopaminergic or noradrenergic enhancement (Gratton et al., 2017) . We found a similar facilitatory effect on the spatial suppression of perceived contrast after caffeine ingestion, which we attribute to a likely enhancement of the cholinergic, rather than noradrenergic or dopaminergic, pathway. However, acetylcholine does not operate in isolation, but influences other neuromodulator levels. For example, in rodent cortex, stimulation of muscarinic cholinergic receptors inhibits the release of gamma-aminobutyric acid (GABA) (Sugita et al., 1991) , a key inhibitory neuromodulator involved in perceptual surround suppression (Yoon et al., 2010) . Furthermore, application of acetylcholine to visual cortical neurones in marmoset monkeys broadens their orientation tuning -an effect that is attributed to reduced GABA-ergic inhibition (Zinke et al., 2006) . Hence, it is possible that our observed effects result from a complex cascade of altered neuromodulation, which either only acts on the non-oriented component of suppression, or alternately reduces the orientation specificity of the effect. Future work investigating the effect of caffeine on visual perception could incorporate human neuroimaging methods that enable in vivo measurement of brain metabolites such as GABA (Yoon et al., 2010) to test this idea more directly.
Conclusions
We show that caffeine affects visual perceptual surround suppression of contrast. The effect is present 30-60 min after ingestion of a commercially available caffeine pill (i.e. an absolute, moderate 200 mg dose of caffeine), following a period of caffeine washout (24 h). Firstly, this finding has practical implications on studies utilising such visual behavioural methods to indirectly investigate centresurround interactions in a range of human conditions. Secondly, although the exact biological mechanism of action of caffeine contributing to the visual perceptual changes observed here is yet unknown and falls outside the scope of our experimental design, this study provides evidence from human behavioural work to further understand the mechanisms underlying perceptual surround suppression. Perceptual surround suppression is predominantly attributed to the major cortical inhibitory neurotransmitter, GABA. In this study, we considered the potential for caffeine to exert modulatory effects on cholinergic pathways, and more recent evidence for visual perceptual facilitatory effects from cholinergic (and not noradrenergic or dopaminergic) enhancement. Our results point to the involvement of other neuromodulators, possibly cholinergic, in perceptual surround suppression. Further work is necessary to elucidate the mechanism/s of caffeine (e.g. directly via muscarinic cholinergic enhancement or indirectly via reduction in GABA), that impact on visual perception.
